OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2925
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Polymicrogyria-turricephaly-hypogenitalism syndrome is an extremely rare condition that has been described in medical literature but is now classified as 'obsolete' in disease databases, meaning it may have been reclassified, merged with another condition, or its original description may no longer be considered a distinct syndrome. The name describes three main features: polymicrogyria (a brain malformation where the surface of the brain has too many small folds instead of the normal pattern), turricephaly (a tower-shaped or tall skull), and hypogenitalism (underdevelopment of the genitals or reproductive organs). Because the brain is not formed correctly, affected individuals typically experience intellectual disability, seizures, and developmental delays. The unusual skull shape results from how the skull bones grow and fuse. Underdeveloped genitals may affect sexual development later in life. Because this condition is obsolete in current classification systems, it is possible that patients originally described under this name would today receive a more specific or updated diagnosis. Treatment has been supportive, focusing on managing seizures, providing developmental therapies, and addressing any hormonal or genital abnormalities. There are no specific curative treatments known for this condition.

Key symptoms:

Abnormal brain folds (polymicrogyria)Tower-shaped skullUnderdeveloped genitalsIntellectual disabilitySeizures or epilepsyDevelopmental delaysDifficulty with speech and languageMotor skill difficultiesAbnormal muscle toneFeeding difficulties in infancyShort stature or growth problemsDelayed puberty

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome community →

No specialists are currently listed for OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome.

Start the conversation →

Latest news about OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome

No recent news articles for OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Has modern genetic testing been done to look for a more specific diagnosis?,What type of polymicrogyria does my child have, and how much of the brain is affected?,What is the best approach to controlling seizures, and what are the medication options?,Should my child see a pediatric endocrinologist for the genital underdevelopment?,What developmental therapies would benefit my child the most right now?,Are there any clinical trials or research studies we should consider?,What should I expect in terms of long-term development and independence?

Common questions about OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome

What is OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome?

Polymicrogyria-turricephaly-hypogenitalism syndrome is an extremely rare condition that has been described in medical literature but is now classified as 'obsolete' in disease databases, meaning it may have been reclassified, merged with another condition, or its original description may no longer be considered a distinct syndrome. The name describes three main features: polymicrogyria (a brain malformation where the surface of the brain has too many small folds instead of the normal pattern), turricephaly (a tower-shaped or tall skull), and hypogenitalism (underdevelopment of the genitals or

At what age does OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome typically begin?

Typical onset of OBSOLETE: Polymicrogyria-turricephaly-hypogenitalism syndrome is neonatal. Age of onset can vary across affected individuals.